about
Preexisting insulin autoantibodies predict efficacy of otelixizumab in preserving residual β-cell function in recent-onset type 1 diabetesPrediction of Impending Type 1 Diabetes through Automated Dual-Label Measurement of Proinsulin:C-Peptide Ratio.Minimal functional β-cell mass in intraportal implants that reduces glycemic variability in type 1 diabetic recipients.Twenty-Year Progression Rate to Clinical Onset According to Autoantibody Profile, Age, and HLA-DQ Genotype in a Registry-Based Group of Children and Adults With a First-Degree Relative With Type 1 Diabetes.Hyperglycemic clamp and oral glucose tolerance test for 3-year prediction of clinical onset in persistently autoantibody-positive offspring and siblings of type 1 diabetic patients.Predictive power of screening for antibodies against insulinoma-associated protein 2 beta (IA-2beta) and zinc transporter-8 to select first-degree relatives of type 1 diabetic patients with risk of rapid progression to clinical onset of the disease:Change and stability in depressive symptoms in young adults with type 1 diabetes.Correction: Prediction of Impending Type 1 Diabetes through Automated Dual-Label Measurement of Proinsulin:C-Peptide Ratio.BMI is an important driver of β-cell loss in type 1 diabetes upon diagnosis in 10 to 18-year-old children.The Role of Peers for Diabetes Management in Adolescents and Emerging Adults With Type 1 Diabetes: A Longitudinal Study.Evaluation of the Sebia Capillarys 3 Tera and the Bio-Rad D-100 Systems for the Measurement of Hemoglobin A1c.Psychosocial functioning and glycemic control in emerging adults with Type 1 diabetes: A 5-year follow-up study.A novel LIPS assay for insulin autoantibodies.Illness Identity in Adolescents and Emerging Adults With Type 1 Diabetes: Introducing the Illness Identity Questionnaire.Parenting and Treatment Adherence in Type 1 Diabetes Throughout Adolescence and Emerging Adulthood.Seasonal variation in month of diagnosis in children with type 1 diabetes registered in 23 European centers during 1989-2008: little short-term influence of sunshine hours or average temperature.Accelerated Progression to Type 1 Diabetes in the Presence of HLA-A*24 and -B*18 Is Restricted to Multiple Islet Autoantibody-Positive Individuals With Distinct HLA-DQ and Autoantibody Risk Profiles.Coping with type 1 diabetes through emerging adulthood: Longitudinal associations with perceived control and haemoglobin A1c.Trends and cyclical variation in the incidence of childhood type 1 diabetes in 26 European centres in the 25 year period 1989–2013: a multicentre prospective registration studySudden onset of immune-mediated type 1 diabetes mellitus in a 93-year-old woman: a case reportParental illness intrusiveness and youth glycaemic control in type 1 diabetes: intergenerational associations and processesPersonality Functioning in Adolescents and Emerging Adults With Type 1 DiabetesThe Social Context and Illness Identity in Youth with Type 1 Diabetes: A Three-Wave Longitudinal StudyRelation between Heart Rate Variability and Disease Course in Multiple SclerosisA triadic perspective on control perceptions in youth with type 1 diabetes and their parents: Associations with treatment adherence and glycemic controlDisturbed Eating Behaviors in Adolescents and Emerging Adults With Type 1 Diabetes: A One-Year Prospective Study
P50
Q35207904-1511325A-7F09-4F92-AA6E-1B240398F945Q36209699-F740B453-2E0E-4038-80A7-45EE8F37B5DCQ37277940-D5138945-F80D-498B-A9F7-76A5EABF2A2DQ38682088-56FD8283-6E56-4AE2-9E84-45142D542728Q39096821-F9E5B244-B823-40D4-8607-3A16BE336F39Q39908057-81171A29-DC2D-4444-932C-F5DECC04F202Q41142172-5319A051-0543-4A8F-BCD1-34D2BF3C775BQ42343992-B8527FC5-D75F-4692-B744-8AC91965D28DQ43449247-663306F3-90FA-4E1B-93E3-A1C94DB6E70EQ47608868-C3F8262B-8D07-45D5-9EFB-3DE0A2A84621Q47756501-79A6938D-947F-4DCD-B70D-5EA096F7719CQ48095444-506CCE7A-37F0-4645-ADC1-BDB2BA0538B6Q48300084-282D778B-0304-4AF0-B4FC-D917C8DE39D9Q49064394-F5EBBEB4-B7C4-4328-BBD2-BD4C0993B0EAQ49106850-E2ED7502-64DD-4D24-9232-E2122231D0DDQ50447697-AA94D9B4-91B1-40C3-82F1-0A5880D921FBQ52653252-ED200855-61CF-4C99-ACF4-38A925C6E103Q53170585-ED9F3E85-D234-4A98-ACC0-12F06A70C57CQ61306971-67590B6E-306E-42CA-A5C8-DD04F12F92CBQ89017424-FCF8560D-1C5B-4F8A-9BEC-A9290AC7CC16Q91016674-7B029AE7-D769-4E48-B6F1-1DD38190F28DQ91857299-B5521575-F3E2-44D9-9E0E-BA8FC1752138Q92104090-2F1415AC-E76C-4895-911E-84D8CAC84F7CQ92153038-A24429CD-5C8A-4044-856B-E46EEEC28044Q92574510-7F932C1A-A0C6-4156-BF13-961980A9AEA8Q92882740-BD61FB33-FDBB-4FAA-AE31-2F09CC4BBD16
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ilse Weets
@ast
Ilse Weets
@en
Ilse Weets
@es
Ilse Weets
@nl
type
label
Ilse Weets
@ast
Ilse Weets
@en
Ilse Weets
@es
Ilse Weets
@nl
prefLabel
Ilse Weets
@ast
Ilse Weets
@en
Ilse Weets
@es
Ilse Weets
@nl
P106
P31
P496
0000-0002-9007-5203